The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10820 malaria professionals are enjoying the free benefits of MalariaWorld today

VLP

A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development

April 6, 2021 - 14:24 -- Open Access
Author(s): 
Atcheson E, Hill AVS, Reyes-Sandoval A
Reference: 
NPJ Vaccines. 2021 Apr 1;6(1):46

Malaria continues to be a pressing global health issue, causing nearly half a million deaths per year. An effective malaria vaccine could radically improve our ability to control and eliminate this pathogen. The most advanced malaria vaccine, RTS,S, confers only 30% protective efficacy under field conditions, and hence the search continues for improved vaccines.

Subscribe to RSS - VLP